GPP
LEGN icon

Great Point Partners’s Legend Biotech LEGN Stock Holding History

Great Point Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-113,460
Closed -$3.7M – 39
2025
Q3 		$3.7M Sell
113,460
-236,540
-68% -$8.73M 1.53% 23
2025
Q2 		$12.4M Buy
350,000
+211,760
+153% +$6.86M 8.08% 4
2025
Q1 		$4.69M Buy
+138,240
New +$4.96M 2.48% 18

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Great Point Partners's LEGN Position: Q4 2025 in Review

Great Point Partners sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 113,460 shares — an estimated $3.7M sold.

Great Point Partners first reported a position in LEGN in Q1 2025 and held it in 3 quarters. The position peaked at $12.4M in Q2 2025. 198 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Great Point Partners reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Great Point Partners sold 113,460 Legend Biotech shares in Q4 2025, an estimated $3.7M.
  • Great Point Partners first reported a position in Legend Biotech in Q1 2025 and held it in 3 quarters.
  • Great Point Partners's Legend Biotech position peaked at $12.4M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Great Point Partners's 13F filing for Q4 2025, filed 17 Feb 2026.